We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Procter & Gamble (PG) Beats on Q3 Earnings and Sales, Ups View
Read MoreHide Full Article
The Procter & Gamble Company (PG - Free Report) has reported better-than-expected top and bottom lines in third-quarter fiscal 2023. Sales and earnings improved year over year. The company’s organic sales grew, driven by robust pricing and a favorable mix, along with strength across segments.
Shares of the company gained 1.6% in the pre-market session, following the better-than-expected top and bottom lines, and the raised sales view.
Procter & Gamble’s earnings of $1.37 per share increased 3% from $1.33 in the year-ago quarter. The figure also beat the Zacks Consensus Estimate and our estimate of $1.32. Currency-neutral core earnings per share (EPS) rose 13% year over year.
Procter & Gamble Company (The) Price, Consensus and EPS Surprise
The company has reported net sales of $20,068 million, up 4% year over year. Sales surpassed the Zacks Consensus Estimate of $19,295 million and our estimate of $18,824.6 million. The increase in sales can be attributed to growth across all segments. Currency impacted net sales by 4%.
On an organic basis (excluding the impacts of acquisitions, divestitures and foreign exchange), revenues improved 7%, backed by a 10% rise in pricing and a 1% gain from a positive product mix, offset by a 3% decline in volume.
Net sales increased 3% for Beauty, 1% for Grooming, 6% for Health Care, 5% for Fabric & Home Care, and 3% for the Baby, Feminine & Family Care segments. All the company’s business segments have reported growth in organic sales. Organic sales rose 7% each for Beauty and Grooming segments, 9% each for the Fabric & Home Care and Health Care segments, and 6% for the Baby, Feminine & Family Care segment.
Shares of the Zacks Rank #3 (Hold) company have gained 7% in the past three months compared with the industry’s 6.3% rally.
Image Source: Zacks Investment Research
Margins
In the reported quarter, the gross margin increased 150 basis points (bps) to 48.2%. Favorable currency rates aided the gross margin by 0.7%. The currency-neutral gross margin improved 220 bps to 48.9%. The increase in the gross margin was driven by 470 bps of pricing gains and 210 bps of gross productivity savings, offset by 270-bps commodity and input material cost inflation, a 140-bps impact of negative product mix, and 50-bps of product reinvestments and other impacts.
Selling, general and administrative expenses (SG&A), as a percentage of sales, expanded 100 bps from the year-ago quarter to 27%. Currency hurt the SG&A expense rate by 0.5%. The SG&A expense rate improved 50 bps to 26.5% on a currency-neutral basis, owing to 310 bps of marketing investments, inflation and other impacts, offset by a 180-bps net sales growth leverage and 80-bps of productivity savings.
The operating margin rose 40 bps from the prior year to 21.2%. Currency rates aided the operating margin by 1.2%. On a currency-neutral basis, the operating margin expanded 160 bps to 22.4%. The operating margin included gross productivity savings of 290 bps.
Financials
Procter & Gamble ended third-quarter fiscal 2023 with cash and cash equivalents of $7,596 million, long-term debt of $22,874 million, and total shareholders’ equity of $45,421 million.
The company generated an operating cash flow of $3,863 million in third-quarter fiscal 2023 and an adjusted free cash flow of $3,133 million. Adjusted free cash flow productivity was 92% in the fiscal third quarter.
It returned $3.6 billion of value to its shareholders in the fiscal third quarter. This included $2.2 billion of dividend payouts and $1.4 billion of share buybacks.
Fiscal 2023 Guidance
Management has raised its sales view for fiscal 2023, while it retained its earnings outlook. For fiscal 2023, the company anticipates year-over-year all-in sales growth of 1% compared with down 1% and flat stated earlier. Organic sales are likely to increase 6% in fiscal 2023 versus 4-5% growth mentioned earlier. Currency movements are expected to negatively impact all-in sales growth by 5%.
The company has retained its view for fiscal 2023 EPS. It expects reported EPS to be flat to up 4% from the $5.81 reported in fiscal 2022. However, the company expects EPS at the low end of the prior-mentioned range due to the ongoing commodity and material cost headwinds, and currency impacts.
The current earnings view includes after-tax impacts of $1.3 billion related to unfavorable currency movements, and $2.2 billion of impacts of higher commodity and material costs. This equates to a $3.5-billion after-tax impact on net income, implying a $1.40-per-share impact on EPS or a 24-percentage-point headwind on EPS growth. The revised $3.5-billion headwind marks a modest sequential improvement from the company’s prior view of $3.7 billion.
Procter & Gamble expects the net impact of interest expenses and interest income to be $125 million before tax earnings headwind for fiscal 2023. The company projects a core effective tax rate of 20% for fiscal 2023. It expects capital expenditure to be 4% of net sales in fiscal 2023.
Adjusted free cash flow productivity is estimated to be 90% for fiscal 2023. The company intends to make dividend payments of $9 billion, along with share repurchases of $7.4-$8 billion in fiscal 2023.
Here’s How Better-Ranked Stocks Fared
We highlighted some better-ranked stocks from the broader Consumer Staples space, namely Inter Parfums (IPAR - Free Report) , Nu Skin Enterprises (NUS - Free Report) and Colgate-Palmolive (CL - Free Report) .
Inter Parfums currently sports a Zacks Rank #1 (Strong Buy) and has an expected long-term earnings growth rate of 15%. IPAR has a trailing four-quarter earnings surprise of 36.2%, on average. The company has risen 38.5% in the past three months.
The Zacks Consensus Estimate for Inter Parfums’ current financial-year sales and EPS suggests growth of 10.5% and 0.8%, respectively, from the year-ago reported numbers. The consensus mark for IPAR’s EPS has been unchanged in the past 30 days.
Nu Skin currently carries a Zacks Rank of 2 (Buy). NUS has a trailing four-quarter earnings surprise of 7.4%, on average. The company has declined 2.3% in the past three months.
The Zacks Consensus Estimate for NUS’ current financial year’s sales and earnings suggests declines of 5.7% and 11%, respectively, from the prior-year reported numbers. The consensus mark for NUS’ EPS has moved up by a penny in the past seven days.
Colgate currently carries a Zacks Rank #2. CL has a trailing four-quarter earnings surprise of 0.4%, on average. It has a long-term earnings growth rate of 6.2%. The company has increased 1.2% in the past three months.
The Zacks Consensus Estimate for Colgate’s current financial year’s sales and EPS suggests growth of 5% and 4.4%, respectively, from the year-ago reported numbers. The consensus mark for CL’s EPS has been unchanged in the past 30 days.
Unique Zacks Analysis of Your Chosen Ticker
Pick one free report - opportunity may be withdrawn at any time
Image: Bigstock
Procter & Gamble (PG) Beats on Q3 Earnings and Sales, Ups View
The Procter & Gamble Company (PG - Free Report) has reported better-than-expected top and bottom lines in third-quarter fiscal 2023. Sales and earnings improved year over year. The company’s organic sales grew, driven by robust pricing and a favorable mix, along with strength across segments.
Shares of the company gained 1.6% in the pre-market session, following the better-than-expected top and bottom lines, and the raised sales view.
Procter & Gamble’s earnings of $1.37 per share increased 3% from $1.33 in the year-ago quarter. The figure also beat the Zacks Consensus Estimate and our estimate of $1.32. Currency-neutral core earnings per share (EPS) rose 13% year over year.
Procter & Gamble Company (The) Price, Consensus and EPS Surprise
Procter & Gamble Company (The) price-consensus-eps-surprise-chart | Procter & Gamble Company (The) Quote
The company has reported net sales of $20,068 million, up 4% year over year. Sales surpassed the Zacks Consensus Estimate of $19,295 million and our estimate of $18,824.6 million. The increase in sales can be attributed to growth across all segments. Currency impacted net sales by 4%.
On an organic basis (excluding the impacts of acquisitions, divestitures and foreign exchange), revenues improved 7%, backed by a 10% rise in pricing and a 1% gain from a positive product mix, offset by a 3% decline in volume.
Net sales increased 3% for Beauty, 1% for Grooming, 6% for Health Care, 5% for Fabric & Home Care, and 3% for the Baby, Feminine & Family Care segments. All the company’s business segments have reported growth in organic sales. Organic sales rose 7% each for Beauty and Grooming segments, 9% each for the Fabric & Home Care and Health Care segments, and 6% for the Baby, Feminine & Family Care segment.
Shares of the Zacks Rank #3 (Hold) company have gained 7% in the past three months compared with the industry’s 6.3% rally.
Image Source: Zacks Investment Research
Margins
In the reported quarter, the gross margin increased 150 basis points (bps) to 48.2%. Favorable currency rates aided the gross margin by 0.7%. The currency-neutral gross margin improved 220 bps to 48.9%. The increase in the gross margin was driven by 470 bps of pricing gains and 210 bps of gross productivity savings, offset by 270-bps commodity and input material cost inflation, a 140-bps impact of negative product mix, and 50-bps of product reinvestments and other impacts.
Selling, general and administrative expenses (SG&A), as a percentage of sales, expanded 100 bps from the year-ago quarter to 27%. Currency hurt the SG&A expense rate by 0.5%. The SG&A expense rate improved 50 bps to 26.5% on a currency-neutral basis, owing to 310 bps of marketing investments, inflation and other impacts, offset by a 180-bps net sales growth leverage and 80-bps of productivity savings.
The operating margin rose 40 bps from the prior year to 21.2%. Currency rates aided the operating margin by 1.2%. On a currency-neutral basis, the operating margin expanded 160 bps to 22.4%. The operating margin included gross productivity savings of 290 bps.
Financials
Procter & Gamble ended third-quarter fiscal 2023 with cash and cash equivalents of $7,596 million, long-term debt of $22,874 million, and total shareholders’ equity of $45,421 million.
The company generated an operating cash flow of $3,863 million in third-quarter fiscal 2023 and an adjusted free cash flow of $3,133 million. Adjusted free cash flow productivity was 92% in the fiscal third quarter.
It returned $3.6 billion of value to its shareholders in the fiscal third quarter. This included $2.2 billion of dividend payouts and $1.4 billion of share buybacks.
Fiscal 2023 Guidance
Management has raised its sales view for fiscal 2023, while it retained its earnings outlook. For fiscal 2023, the company anticipates year-over-year all-in sales growth of 1% compared with down 1% and flat stated earlier. Organic sales are likely to increase 6% in fiscal 2023 versus 4-5% growth mentioned earlier. Currency movements are expected to negatively impact all-in sales growth by 5%.
The company has retained its view for fiscal 2023 EPS. It expects reported EPS to be flat to up 4% from the $5.81 reported in fiscal 2022. However, the company expects EPS at the low end of the prior-mentioned range due to the ongoing commodity and material cost headwinds, and currency impacts.
The current earnings view includes after-tax impacts of $1.3 billion related to unfavorable currency movements, and $2.2 billion of impacts of higher commodity and material costs. This equates to a $3.5-billion after-tax impact on net income, implying a $1.40-per-share impact on EPS or a 24-percentage-point headwind on EPS growth. The revised $3.5-billion headwind marks a modest sequential improvement from the company’s prior view of $3.7 billion.
Procter & Gamble expects the net impact of interest expenses and interest income to be $125 million before tax earnings headwind for fiscal 2023. The company projects a core effective tax rate of 20% for fiscal 2023. It expects capital expenditure to be 4% of net sales in fiscal 2023.
Adjusted free cash flow productivity is estimated to be 90% for fiscal 2023. The company intends to make dividend payments of $9 billion, along with share repurchases of $7.4-$8 billion in fiscal 2023.
Here’s How Better-Ranked Stocks Fared
We highlighted some better-ranked stocks from the broader Consumer Staples space, namely Inter Parfums (IPAR - Free Report) , Nu Skin Enterprises (NUS - Free Report) and Colgate-Palmolive (CL - Free Report) .
Inter Parfums currently sports a Zacks Rank #1 (Strong Buy) and has an expected long-term earnings growth rate of 15%. IPAR has a trailing four-quarter earnings surprise of 36.2%, on average. The company has risen 38.5% in the past three months.
You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for Inter Parfums’ current financial-year sales and EPS suggests growth of 10.5% and 0.8%, respectively, from the year-ago reported numbers. The consensus mark for IPAR’s EPS has been unchanged in the past 30 days.
Nu Skin currently carries a Zacks Rank of 2 (Buy). NUS has a trailing four-quarter earnings surprise of 7.4%, on average. The company has declined 2.3% in the past three months.
The Zacks Consensus Estimate for NUS’ current financial year’s sales and earnings suggests declines of 5.7% and 11%, respectively, from the prior-year reported numbers. The consensus mark for NUS’ EPS has moved up by a penny in the past seven days.
Colgate currently carries a Zacks Rank #2. CL has a trailing four-quarter earnings surprise of 0.4%, on average. It has a long-term earnings growth rate of 6.2%. The company has increased 1.2% in the past three months.
The Zacks Consensus Estimate for Colgate’s current financial year’s sales and EPS suggests growth of 5% and 4.4%, respectively, from the year-ago reported numbers. The consensus mark for CL’s EPS has been unchanged in the past 30 days.